Literature DB >> 20675514

52-year-old woman with dysphagia.

Sahil Khanna1, Amit Noheria, Charles H Rohren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20675514      PMCID： PMC2912738          DOI： 10.4065/mcp.2009.0353

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  29 in total

1.  Multiple ulcerative esophagitis caused by alendronate.

Authors:  G Maconi; G Bianchi Porro
Journal:  Am J Gastroenterol       Date:  1995-10       Impact factor: 10.864

2.  Eosinophilic esophagitis.

Authors:  D Picus; P H Frank
Journal:  AJR Am J Roentgenol       Date:  1981-05       Impact factor: 3.959

3.  The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children.

Authors:  S R Orenstein; T M Shalaby; C Di Lorenzo; P E Putnam; L Sigurdsson; H Mousa; S A Kocoshis
Journal:  Am J Gastroenterol       Date:  2000-06       Impact factor: 10.864

4.  Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism.

Authors:  Anil Mishra; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

5.  Eosinophilic esophagitis in children: symptoms, histology and pH probe results.

Authors:  A M G A Sant'Anna; S Rolland; J C Fournet; S Yazbeck; E Drouin
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-10       Impact factor: 2.839

6.  Eosinophilic esophagitis in a patient with vigorous achalasia.

Authors:  R T Landres; G G Kuster; W B Strum
Journal:  Gastroenterology       Date:  1978-06       Impact factor: 22.682

7.  Correlation between number of eosinophils and reflux index on same day esophageal biopsy and 24 hour esophageal pH monitoring.

Authors:  Steven J Steiner; Sandeep K Gupta; Joseph M Croffie; Joseph F Fitzgerald
Journal:  Am J Gastroenterol       Date:  2004-05       Impact factor: 10.864

Review 8.  Eosinophilic esophagitis.

Authors:  Anand R Gupte; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

9.  Eosinophilic oesophagitis: a novel treatment using Montelukast.

Authors:  S E A Attwood; C J Lewis; C S Bronder; C D Morris; G R Armstrong; J Whittam
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

10.  Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.

Authors:  Jennifer K Garrett; Sean C Jameson; Blythe Thomson; Margaret H Collins; Lynne E Wagoner; Debbie K Freese; Lisa A Beck; Joshua A Boyce; Alexandra H Filipovich; Joyce M Villanueva; Steven A Sutton; Amal H Assa'ad; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2003-12-12       Impact factor: 10.793
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.